Literature DB >> 12490818

Infection and urinary stones.

Harrison M Abrahams1, Marshall L Stoller.   

Abstract

PURPOSE OF REVIEW: Despite modern antibiotic therapy and technological advances in lithotripsy, the presence of infection in urinary stone patients as well as infectious stones are still a significant cause of morbidity and mortality. Many new investigations are focusing on the pathogenesis and treatment of these difficult cases. RECENT
FINDINGS: Most of the current literature on the subject focuses on pathogenesis of infectious urinary stones. The remaining literature highlights difficult cases, outcomes of treatments, and overall reviews of the subject.
SUMMARY: Recent findings lend more theories as to how infection leads to stone formation. Further investigation is critically needed to improve the outcomes of patients suffering from infections with urinary stones and infectious stones.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490818     DOI: 10.1097/00042307-200301000-00011

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  11 in total

1.  Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones.

Authors:  Amy E Krambeck; Naseem F Khan; Molly E Jackson; James E Lingeman; James A McAteer; James C Williams
Journal:  J Urol       Date:  2010-08-21       Impact factor: 7.450

2.  High carbonate level of apatite in kidney stones implies infection, but is it predictive?

Authors:  Kate M Englert; James A McAteer; James E Lingeman; James C Williams
Journal:  Urolithiasis       Date:  2013-07-24       Impact factor: 3.436

3.  Stability of the infection marker struvite in urinary stone samples.

Authors:  James C Williams; Andrew J Sacks; Kate Englert; Rachel Deal; Takeisha L Farmer; Molly E Jackson; James E Lingeman; James A McAteer
Journal:  J Endourol       Date:  2011-10-11       Impact factor: 2.942

4.  Precipitation of amorphous magnesium ammonium phosphate: is it a precursor for staghorn stones?

Authors:  Jong Wook Kim; Cheol Yong Yoon; Hong Seok Park; Jeong Gu Lee; Du Geon Moon; Mi Mi Oh
Journal:  Urolithiasis       Date:  2014-03-19       Impact factor: 3.436

Review 5.  ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis.

Authors:  T M Reynolds
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

6.  Management of urinary tract infections associated with nephrolithiasis.

Authors:  Patricia D Brown
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

7.  Persistent Escherichia coli infection in renal tubular cells enhances calcium oxalate crystal-cell adhesion by inducing ezrin translocation to apical membranes via Rho/ROCK pathway.

Authors:  Rattiyaporn Kanlaya; Visith Thongboonkerd
Journal:  Cell Mol Life Sci       Date:  2022-06-24       Impact factor: 9.261

8.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

9.  Patients' poor performance status is an independent risk factor for urosepsis induced by kidney and ureteral stones.

Authors:  Mika Kino; Takumi Hayashi; Daichi Hino; Takako Nakada; Hiroki Kitoh; Koichiro Akakura
Journal:  Urolithiasis       Date:  2021-03-23       Impact factor: 3.436

10.  A Drosophila model identifies a critical role for zinc in mineralization for kidney stone disease.

Authors:  Thomas Chi; Man Su Kim; Sven Lang; Neelanjan Bose; Arnold Kahn; Lawrence Flechner; Sarah D Blaschko; Tiffany Zee; Gulinuer Muteliefu; Nichole Bond; Marysia Kolipinski; Sirine C Fakra; Neil Mandel; Joe Miller; Arvind Ramanathan; David W Killilea; Katja Brückner; Pankaj Kapahi; Marshall L Stoller
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.